MA69005B1 - Compositions et procédés pour la stabilisation de micro-arn - Google Patents

Compositions et procédés pour la stabilisation de micro-arn

Info

Publication number
MA69005B1
MA69005B1 MA69005A MA69005A MA69005B1 MA 69005 B1 MA69005 B1 MA 69005B1 MA 69005 A MA69005 A MA 69005A MA 69005 A MA69005 A MA 69005A MA 69005 B1 MA69005 B1 MA 69005B1
Authority
MA
Morocco
Prior art keywords
microrna
compositions
stabilizing
methods
micrornas
Prior art date
Application number
MA69005A
Other languages
English (en)
Inventor
Zouher Majd
Original Assignee
Genfit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfit filed Critical Genfit
Publication of MA69005B1 publication Critical patent/MA69005B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/30—Characterised by physical treatment
    • C12Q2523/31—Electrostatic interactions, e.g. use of cationic polymers in hybridisation reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/207—Modifications characterised by siRNA, miRNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00—Reactions demanding special reaction conditions
    • C12Q2527/125—Specific component of sample, medium or buffer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00—Reactions demanding special reaction conditions
    • C12Q2527/143—Concentration of primer or probe
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00—Reactions characterised by their quantitative nature
    • C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/101—Reactions characterised by their quantitative nature the purpose being quantitative analysis with an internal standard/control
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00—Reactions characterised by their quantitative nature
    • C12Q2545/10—Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/107—Reactions characterised by their quantitative nature the purpose being quantitative analysis with a competitive internal standard/control
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne la stabilisation de molécules de micro-ARN. Les compositions et méthodes décrites ici peuvent être avantageusement utilisées pour la fourniture de microARN de contrôle interne et standard destinés à être inclus dans des kits, utiles pour la quantification normalisée, relative ou absolue d'un microARN dans un fluide biologique.
MA69005A 2019-04-16 2020-04-16 Compositions et procédés pour la stabilisation de micro-arn MA69005B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19305496 2019-04-16
EP23164521.9A EP4223886B1 (fr) 2019-04-16 2020-04-16 Compositions et procédés pour la stabilisation de micro-arn

Publications (1)

Publication Number Publication Date
MA69005B1 true MA69005B1 (fr) 2025-01-31

Family

ID=66334331

Family Applications (1)

Application Number Title Priority Date Filing Date
MA69005A MA69005B1 (fr) 2019-04-16 2020-04-16 Compositions et procédés pour la stabilisation de micro-arn

Country Status (19)

Country Link
US (1) US20220186313A1 (fr)
EP (2) EP3956470A1 (fr)
JP (2) JP2022529035A (fr)
KR (1) KR20210153077A (fr)
CN (1) CN113661251B (fr)
AU (1) AU2020259847B2 (fr)
CA (1) CA3130522A1 (fr)
DK (1) DK4223886T3 (fr)
EA (1) EA202192832A1 (fr)
ES (1) ES3005085T3 (fr)
FI (1) FI4223886T3 (fr)
IL (1) IL286580B2 (fr)
MA (1) MA69005B1 (fr)
MX (1) MX2021012610A (fr)
PL (1) PL4223886T3 (fr)
PT (1) PT4223886T (fr)
TW (1) TWI866964B (fr)
WO (1) WO2020212522A1 (fr)
ZA (1) ZA202109058B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12458612B2 (en) 2019-04-10 2025-11-04 Genfit Combination therapy comprising compounds of formula (I) and GLP-1 receptor agonists
GB2594317B (en) * 2020-04-23 2022-05-25 Univ Johannesburg Witwatersrand SARS-CoV-2 Diagnostic control compositions
CN115737557B (zh) * 2022-11-18 2024-04-09 黑龙江中医药大学 一种miR-55制剂及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334761A (en) 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
JPH09500013A (ja) 1993-06-01 1997-01-07 ライフ・テクノロジーズ・インコーポレイテッド カチオン性脂質による遺伝子免疫
US5578475A (en) 1993-07-12 1996-11-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
US5674908A (en) 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
WO1996040961A1 (fr) 1995-06-07 1996-12-19 Life Technologies, Inc. Transfection par lipides cationiques amelioree par des peptides
US20030069173A1 (en) 1998-03-16 2003-04-10 Life Technologies, Inc. Peptide-enhanced transfections
US6051429A (en) 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
NZ512244A (en) 1998-11-12 2003-12-19 Invitrogen Corp Polycationic transfection reagents for introducing anions into a cell
EP1337664A4 (fr) 2000-10-27 2005-01-19 Invitrogen Corp Procede d'introduction d'oligonucleotides antisens dans des cellules eucaryotes
GB0313132D0 (en) * 2003-06-06 2003-07-09 Ich Productions Ltd Peptide ligands
US7404969B2 (en) * 2005-02-14 2008-07-29 Sirna Therapeutics, Inc. Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
WO2006102163A2 (fr) 2005-03-17 2006-09-28 Invitrogen Corporation Reactifs de transfection pour cellules en suspension non adherentes
US20130130927A1 (en) * 2010-03-11 2013-05-23 Helen Heneghan Detection and quantification of micrornas in the circulation and the use of circulating micrornas as biomarkers for cancer
ES2702428T3 (es) * 2010-11-15 2019-02-28 Life Technologies Corp Reactivos de transfección que contienen amina y métodos para prepararlos y usarlos
CN103205483B (zh) * 2012-01-13 2017-02-08 北京命码生科科技有限公司 microRNA标准化的内参基因及其用途
US20150080229A1 (en) * 2012-03-29 2015-03-19 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Plasma microribonucleic acids as biomarkers for endometriosis and endometriosis-associated ovarian cancer
WO2013148151A1 (fr) * 2012-03-29 2013-10-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Acides microribonucléiques plasmatiques à titre de biomarqueurs de l'endométriose et du cancer de l'ovaire associé à l'endométriose (eaoc)
US10195280B2 (en) 2014-07-15 2019-02-05 Life Technologies Corporation Compositions and methods for efficient delivery of molecules to cells
EP3337900B1 (fr) * 2015-08-20 2021-04-07 Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE Méthodes et compositions pour traiter des maladies et des troubles hépatiques
JP2017093377A (ja) * 2015-11-26 2017-06-01 国立大学法人 東京医科歯科大学 肝がんモデルマウスおよび肝がん治療用の医薬
WO2017167934A1 (fr) 2016-03-30 2017-10-05 Genfit Diagnostic non invasif de la stéatose hépatique non alcoolique
CA3073851A1 (fr) 2017-08-31 2019-03-07 Life Technologies Corporation Compositions lipidiques cationiques pour administration specifique a un tissu

Also Published As

Publication number Publication date
WO2020212522A1 (fr) 2020-10-22
AU2020259847A1 (en) 2021-11-04
PT4223886T (pt) 2024-12-20
KR20210153077A (ko) 2021-12-16
BR112021020664A2 (pt) 2021-12-07
EP4223886B1 (fr) 2024-10-02
CN113661251B (zh) 2024-08-23
IL286580B1 (en) 2024-09-01
CN113661251A (zh) 2021-11-16
DK4223886T3 (da) 2025-01-02
TWI866964B (zh) 2024-12-21
FI4223886T3 (fi) 2024-12-27
IL286580A (en) 2021-10-31
ZA202109058B (en) 2025-05-28
TW202104599A (zh) 2021-02-01
EA202192832A1 (ru) 2022-01-19
EP4223886A3 (fr) 2023-09-13
JP2022529035A (ja) 2022-06-16
PL4223886T3 (pl) 2025-03-31
IL286580B2 (en) 2025-01-01
EP3956470A1 (fr) 2022-02-23
MX2021012610A (es) 2021-11-12
CA3130522A1 (fr) 2020-10-22
ES3005085T3 (en) 2025-03-13
EP4223886A2 (fr) 2023-08-09
AU2020259847B2 (en) 2024-09-19
JP2025067916A (ja) 2025-04-24
US20220186313A1 (en) 2022-06-16

Similar Documents

Publication Publication Date Title
MA69005B1 (fr) Compositions et procédés pour la stabilisation de micro-arn
MA32134B1 (fr) Composés hétérocycliques
MA31763B1 (fr) Inhibiteurs de kinase de type polo
MA31151B1 (fr) Inhibiteurs de mapk/erk kinase
MA32615B1 (fr) Inhibiteurs de cmet
MA51530B1 (fr) Composés cycliques fondus
MA45598B1 (fr) Stéroles 24-hydroxylés substitués en position 11 pour le traitement des maladies liées au récepteur nmda
CL2008001303A1 (es) Compuestos derivados de heterociclos, moduladores de gamma secretasa; composicion farmaceutica; kit farmaceutico; y uso en el tratamiento del alzheimer.
MA33653B1 (fr) Couche colorée amovible pour revêtements d'ongles artificiels et procédés pour celle-ci
ATE531769T1 (de) Verwendung von estern als koaleszenzmittel
FR3030261B1 (fr) Composition comprenant des particules de polymere stabilise et un polymere filmogene hydrophobe
GT200600283A (es) COMPUESTOS DE AMINO-5-HETEROARILO (5 MIEMBROS) IMIDAZOLONA Y SU USO PARA LA MODULACIÓN DE LA beta-SECRETASA
BR9917365A (pt) Processo de tratamento de fluidos substancialmente aquosos
BR112013005656A2 (pt) processo para revestir superfícies metálicas com um agente de revestimento que contém um polímero, o agente de revestimento e uso do mesmo
EP1740559A4 (fr) Derives de phenyle 1,3,5-substitues utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer
MA30405B1 (fr) Derives de 4-benzylphtalazinone substitues en 2 en tant qu'antagonistes des histamines hl et h3
MA38240A1 (fr) Nouveaux composes dimeres substitues antagonistes de l'iap utiles pour le traitement du cancer, de preference des tumeurs solides
EA201070804A1 (ru) (аза)индольное производное, замещенное по положению 5, содержащая его фармацевтическая композиция, промежуточные соединения и способ их получения
EP3752486A4 (fr) Cyanines d'heptaméthine destinées à être utilisées en tant que marqueurs fluorescents des systèmes biliaires et rénaux
MX2007014405A (es) Novedosos derivados de oxadiazol y su uso como moduladores aloestericos positivos de los receptores de glutamato metabotropicos.
ATE493397T1 (de) Neuartige tetrazolderivate als positive allosterische modulatoren von metabotropen glutamatrezeptoren
FR3030256B1 (fr) Compositon sous forme d'une emulsion inverse comprenant des particules de polymere, au moins un tensioactif et de l'eau
BRPI0819407A2 (pt) "composto, composição de tintura, processo para tingir e uso de um composto"
MA49267B1 (fr) Low energy curing offset and letterpress printing inks and printing process
FR3055630B1 (fr) Composition bitumineuse pour enrobes a module eleve